0001589361-17-000001.txt : 20170825 0001589361-17-000001.hdr.sgml : 20170825 20170825164327 ACCESSION NUMBER: 0001589361-17-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170825 DATE AS OF CHANGE: 20170825 EFFECTIVENESS DATE: 20170825 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Mount TAM Biotechnologies, Inc. CENTRAL INDEX KEY: 0001589361 STANDARD INDUSTRIAL CLASSIFICATION: TOBACCO PRODUCTS [2100] IRS NUMBER: 453797537 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-293524 FILM NUMBER: 171052447 BUSINESS ADDRESS: STREET 1: 8001 REDWOOD BOULEVARD CITY: NOVATO STATE: CA ZIP: 94925 BUSINESS PHONE: (425) 214-4079 MAIL ADDRESS: STREET 1: 8001 REDWOOD BOULEVARD CITY: NOVATO STATE: CA ZIP: 94925 FORMER COMPANY: FORMER CONFORMED NAME: TabacaleraYsidron, Inc. DATE OF NAME CHANGE: 20140206 FORMER COMPANY: FORMER CONFORMED NAME: TABACALERAYSIDRON INC DATE OF NAME CHANGE: 20140206 FORMER COMPANY: FORMER CONFORMED NAME: TABACALERA YSIDRON INC DATE OF NAME CHANGE: 20131016 D 1 primary_doc.xml X0708 D LIVE 0001589361 Mount TAM Biotechnologies, Inc. 8001 REDWOOD BOULEVARD NOVATO CA CALIFORNIA 94925 (425) 214-4079 NEVADA TabacaleraYsidron, Inc. TABACALERAYSIDRON INC TABACALERA YSIDRON INC Corporation true James Stapleton 8001 Redwood Boulevard Novato CA CALIFORNIA 94924 Executive Officer Richard Marshak 8001 Redwood Boulevard Novato CA CALIFORNIA 94924 Executive Officer Director Brian Kennedy 8001 Redwood Boulevard Novato CA CALIFORNIA 94924 Director Timothy Powers 8001 Redwood Boulevard Novato CA CALIFORNIA 94924 Director Chester Aldridge 8001 Redwood Boulevard Novato CA CALIFORNIA 94924 Director Biotechnology Decline to Disclose 06b false 2017-08-11 false true true false 25000 Young America Capital, LLC None None None 141 East Boston Post Road Mamaroneck NY NEW YORK 10543 CA CALIFORNIA false 2000000 525000 1475000 false 2 160000 true 0 Placement agent will received (i) cash fee of up to 8% of the aggregate gross proceeds received in this offering from investors introduced by the placement agent, and (ii) 2% of the aggregate proceeds from investors introduced by the company. 0 false Mount TAM Biotechnologies, Inc. James Stapleton James Stapleton CFO 2017-08-25